UBS Group’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-196,000
Closed -$18.6M 8583
2018
Q3
$18.6M Sell
196,000
-24,400
-11% -$2.08M 0.01% 1260
2018
Q2
$17M Sell
220,400
-10,600
-5% -$795K 0.01% 1289
2018
Q1
$16M Buy
231,000
+163,600
+243% +$12.5M 0.01% 1316
2017
Q4
$5.03M Hold
67,400
﹤0.01% 2350
2017
Q3
$4.27M Sell
67,400
-31,800
-32% -$1.98M ﹤0.01% 2365
2017
Q2
$6.33M Sell
99,200
-234,000
-70% -$14.7M ﹤0.01% 1924
2017
Q1
$22M Sell
333,200
-188,800
-36% -$13M 0.01% 976
2016
Q4
$35.9M Buy
522,000
+159,500
+44% +$11.4M 0.02% 694
2016
Q3
$25.6M Buy
362,500
+325,500
+880% +$24.3M 0.02% 826
2016
Q2
$2.81M Sell
37,000
-127,000
-77% -$9.34M ﹤0.01% 2487
2016
Q1
$11.3M Buy
164,000
+44,700
+37% +$3.21M 0.01% 1250
2015
Q4
$10.4M Buy
119,300
+84,200
+240% +$7.21M 0.01% 1379
2015
Q3
$2.84M Sell
35,100
-52,000
-60% -$4.53M ﹤0.01% 2430
2015
Q2
$7.75M Sell
87,100
-67,000
-43% -$5.85M 0.01% 1676
2015
Q1
$13.4M Sell
154,100
-1,500
-1% -$126K 0.01% 1237
2014
Q4
$13.2M Buy
+155,600
New +$12.2M 0.01% 1289

Other funds holding ESRX

UBS Group's ESRX Position: Q4 2018 in Review

UBS Group sold out of Express Scripts Holding Company (ESRX) in Q4 2018, closing a stake of 1,689,763 shares — an estimated $161M sold.

UBS Group first reported a position in ESRX in Q4 2014 and held it in 16 quarters. The position peaked at $277M in Q4 2014. 16 funds tracked by Wall St. Rank hold ESRX as of Q4 2018.

  • UBS Group reported no remaining Express Scripts Holding Company position as of Q4 2018 after selling out during the quarter.
  • UBS Group sold 1,689,763 Express Scripts Holding Company shares in Q4 2018, an estimated $161M.
  • UBS Group first reported a position in Express Scripts Holding Company in Q4 2014 and held it in 16 quarters.
  • UBS Group's Express Scripts Holding Company position peaked at $277M in Q4 2014.
  • 16 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2018.

Based on UBS Group's 13F filing for Q4 2018, filed 14 Feb 2019.